eli lily tirzepatide FDA approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Lilly Eli Lilly Says Its Obesity

240 Animal research suggests treatment with gynostemma can induce gene expression changes that may result in decreased diet-related adipose tissue growth, weight gain, and metabolic disturbance

Many patients with cancer are anemic, thrombocytopenic, or prone to bleeding, which should also be taken into account when prescribing anticoagulation

Most people begin noticing appetite suppression within 3-7 days and see measurable weight reduction within 4-8 weeks of consistent use

In clinical trials, acute pancreatitis occurred at a rate of 0.23 patients per 100 years of exposure for tirzepatide versus 0.11 for comparator treatments

Several people have been arrested and face serious criminal charges for trafficking unlicensed medicines